3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
3
Ovarian Neoplasms
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Osteosarcoma
1
Fanconi Anemia, Complementation Group D1
1
Chondrosarcoma
1
Bone Neoplasms
1
Interventions
spartalizumab
1
pegylated granulocyte colony-stimulating factor
1
anlotinib
1
Trabectedin
1
Surgical Navigation Systems
1
Surgery, Computer-Assisted
1
Polymethyl Methacrylate
1
Nivolumab
1
Microbiota
1
Methotrexate
1
Metabolome
1
Ipilimumab
1
Doxorubicin
1
Cisplatin
1
Bone Plates
1
Bone Cements
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Bone Neoplasms
×
Trabectedin
×
Clear all
NCT05131386
2023-03-27
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Unknown
85 enrolled